Basics |
Company: |
Co-Diagnostics, Inc. |
IPO Date: |
July 12, 2017 |
Sector: |
Healthcare |
Industry: |
Medical Diagnostics and Research |
Market Cap: |
$22.51M |
Activated in VL: |
True |
Average Daily Range |
Avg Daily Range: |
$0.23 | 4.13%
|
Avg Daily Range (30 D): |
$0.03 | 3.43%
|
Avg Daily Range (90 D): |
$0.03 | 3.33%
|
Institutional Daily Volume |
Avg Daily Volume: |
1.08M |
Avg Daily Volume (30 D): |
.11M |
Avg Daily Volume (90 D): |
.13M |
Trade Size |
Avg Trade Size (Sh.): |
214 |
Avg Trade Size (Sh.) (30 D): |
403 |
Avg Trade Size (Sh.) (90 D): |
403 |
Institutional Trades |
Total Inst.Trades: |
441 |
Avg Inst. Trade: |
$1.25M |
Avg Inst. Trade (30 D): |
$.7M |
Avg Inst. Trade (90 D): |
$.7M |
Avg Inst. Trade Volume: |
.08M |
Avg Inst. Trades (Per Day): |
2 |
Market Closing Trades |
Avg Closing Trade: |
$1.98M |
Avg Closing Trade (30 D): |
$M |
Avg Closing Trade (90 D): |
$M |
Avg Closing Volume: |
140.98K |
|
|
|
|
Financials |
|
TTM |
Q3 2024 |
Q2 2024 |
Basic EPS
|
$-1.38
|
$-.32
|
$-.25
|
Diluted EPS
|
$-1.38
|
$-.32
|
$-.25
|
Revenue
|
$ 7.32M
|
$ .64M
|
$ 2.66M
|
Gross Profit
|
$ 3.61M
|
$ .34M
|
$ 2.44M
|
Net Income / Loss
|
$ -41.28M
|
$ -9.7M
|
$ -7.6M
|
Operating Income / Loss
|
$ -40M
|
$ -10.23M
|
$ -7.68M
|
Cost of Revenue
|
$ 3.71M
|
$ .3M
|
$ .21M
|
Net Cash Flow
|
$ -8.06M
|
$ M
|
$ M
|
PE Ratio
|
|
|
|
|